42 research outputs found

    Π‘ΠΎΠ΄Π΅Ρ€ΠΆΠ°Π½ΠΈΠ΅ ΠΌΠΈΠΎΠΊΠΈΠ½ΠΎΠ² Π² сывороткС ΠΊΡ€ΠΎΠ²ΠΈ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с эндогСнным Π³ΠΈΠΏΠ΅Ρ€ΠΊΠΎΡ€Ρ‚ΠΈΡ†ΠΈΠ·ΠΌΠΎΠΌ ΠΈ Π°ΠΊΡ€ΠΎΠΌΠ΅Π³Π°Π»ΠΈΠ΅ΠΉ: ΠΎΠ΄Π½ΠΎΠΌΠΎΠΌΠ΅Π½Ρ‚Π½ΠΎΠ΅ исслСдованиС Β«ΡΠ»ΡƒΡ‡Π°ΠΉβˆ’ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒΒ»

    Get PDF
    Background:Β Myokines are produced and released by muscle cells in response to muscular contractions. Endogenous Cushing syndrome (CS) and acromegaly cause significant changes in muscle tissue leading to atrophy or hypertrophy. However, there is no data whether these endocrine abnormalities influence myokine secretion.Β Aims: To evaluate serum levels of myostatin, interleukin-6 (IL6) and irisin in patients with CS and acromegaly.Β Materials and methods: Fasting serum samples were taken and stored in aliquot at ≀-20Β°C from consecutive subjects with clinically evident and biochemically confirmed active CS, acromegaly and healthy volunteers matched by age, sex and body mass index (BMI). Commercially available kits were used to assay serum myokine levels. Grip strength was measured by a dynamometer. Insulin-like growth factor-1 (IGF1) was measured by immunochemiluminescence assay (Liaison), twenty-four hours urine free cortisol (24hUFC) ― by immunochemiluminescence assay (Vitros ECi), salivary free cortisol ― by electrochemiluminescence assay (Cobas). One-way ANOVA was utilized to assess the difference between groups.Β Results: We enrolled 88 subjects: 30 patients suffered from CS (group 1), 28 ― acromegaly (2) and 30 matched healthy controls (3) with no difference among the groups in sex, age and BMI (p=0.492, 0.062 and 0.174 respectively). Mean 24hUFC in subjects with CS and mean IGF1 in subjects with acromegaly were significantly higher as compared to other groups (p0.001). Right-hand grip strength was lower in patients with CS as compared to both patients with acromegaly and healthy subjects (p=0.04). However, among these young adults we did not find statistically significant differences in measured myokines levels: irisin ― p=0.15; IL6 ― p=0.34; myostatin ― p=0.50. There was a significant correlation between myostatin and irisin in the whole group of people and in every separately analyzed subset of patients (p0.001), but no correlation was found between any measured myokines and 24hUFC or IGF1.Conclusions:Β Hypercortisolism or supraphysiological IGF1 levels do not significantly influence serum levels of myostatin, IL6 and irisin in young adults.РСзюмС: ΠœΠΈΠΎΠΊΠΈΠ½Ρ‹ ΠΏΡ€ΠΎΠ΄ΡƒΡ†ΠΈΡ€ΡƒΡŽΡ‚ΡΡ ΠΈ Π²Ρ‹ΡΠ²ΠΎΠ±ΠΎΠΆΠ΄Π°ΡŽΡ‚ΡΡ ΠΌΠΈΠΎΡ†ΠΈΡ‚Π°ΠΌΠΈ Π² ΠΎΡ‚Π²Π΅Ρ‚ Π½Π° сокращСния ΠΌΡ‹ΡˆΡ†. Π­Π½Π΄ΠΎΠ³Π΅Π½Π½Ρ‹ΠΉ Π³ΠΈΠΏΠ΅Ρ€ΠΊΠΎΡ€Ρ‚ΠΈΡ†ΠΈΠ·ΠΌ ΠΈ акромСгалия Π²Ρ‹Π·Ρ‹Π²Π°ΡŽΡ‚ Π·Π½Π°Ρ‡ΠΈΠΌΡ‹Π΅ измСнСния Π² ΠΌΡ‹ΡˆΠ΅Ρ‡Π½ΠΎΠΉ Ρ‚ΠΊΠ°Π½ΠΈ, приводящиС ΠΊ Π΅Π΅ Π°Ρ‚Ρ€ΠΎΡ„ΠΈΠΈ ΠΈΠ»ΠΈ Π³ΠΈΠΏΠ΅Ρ€Ρ‚Ρ€ΠΎΡ„ΠΈΠΈ. ВмСстС с Ρ‚Π΅ΠΌ, Π½Π΅Ρ‚ Π΄Π°Π½Π½Ρ‹Ρ…, Π²Π»ΠΈΡΡŽΡ‚ Π»ΠΈ эти эндокринныС Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΡ Π½Π° ΡΠ΅ΠΊΡ€Π΅Ρ‚ΠΎΡ€Π½ΡƒΡŽ Ρ„ΡƒΠ½ΠΊΡ†ΠΈΡŽ ΠΌΡ‹ΡˆΡ†.ЦСль: ΠΎΡ†Π΅Π½ΠΈΡ‚ΡŒ сывороточноС содСрТаниС ΠΌΠΈΠΎΠΊΠΈΠ½ΠΎΠ² (ΠΈΠ½Ρ‚Π΅Ρ€Π»Π΅ΠΉΠΊΠΈΠ½-6, миостатин, ΠΈΡ€ΠΈΠ·ΠΈΠ½) Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с эндогСнным Π³ΠΈΠΏΠ΅Ρ€ΠΊΠΎΡ€Ρ‚ΠΈΡ†ΠΈΠ·ΠΌΠΎΠΌ ΠΈ Π°ΠΊΡ€ΠΎΠΌΠ΅Π³Π°Π»ΠΈΠ΅ΠΉ.ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹ ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹: Для провСдСния исслСдования взяты ΠΎΠ±Ρ€Π°Π·Ρ†Ρ‹ сывороток Ρ‚ΠΎΡ‰Π°ΠΊΠΎΠ²ΠΎΠΉ ΠΊΡ€ΠΎΠ²ΠΈ, Π·Π°ΠΌΠΎΡ€ΠΎΠΆΠ΅Π½Π½Ρ‹Π΅ ΠΏΡ€ΠΈ T° ≀-20ΒΊC, Ρƒ Π»ΠΈΡ† с ΠΏΠΎΠ΄Ρ‚Π²Π΅Ρ€ΠΆΠ΄Π΅Π½Π½ΠΎΠΉ Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒΡŽ Π±ΠΎΠ»Π΅Π·Π½ΠΈ Π˜Ρ†Π΅Π½ΠΊΠΎ-ΠšΡƒΡˆΠΈΠ½Π³Π° (Π‘Π˜Πš) ΠΈ Π°ΠΊΡ€ΠΎΠΌΠ΅Π³Π°Π»ΠΈΠΈ ΠΈ Ρƒ Π·Π΄ΠΎΡ€ΠΎΠ²Ρ‹Ρ… Π΄ΠΎΠ±Ρ€ΠΎΠ²ΠΎΠ»ΡŒΡ†Π΅Π², ΠΏΠΎΠ΄ΠΎΠ±Ρ€Π°Π½Π½Ρ‹Ρ… ΠΏΠΎ возрасту, ΠΏΠΎΠ»Ρƒ ΠΈ индСксу массы Ρ‚Π΅Π»Π° (ИМВ). ИсслСдованиС ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½ΠΎ ΠΎΠ΄Π½ΠΎΠΌΠΎΠΌΠ΅Π½Ρ‚Π½ΠΎ Π½Π° Π±Π°Π·Π΅ отдСлСния нСйроэндокринологии ΠΈ остСопатий Π€Π“Π‘Π£ «ЭндокринологичСский Π½Π°ΡƒΡ‡Π½Ρ‹ΠΉ Ρ†Π΅Π½Ρ‚Ρ€Β». Для опрСдСлСния уровня ΠΌΠΈΠΎΠΊΠΈΠ½ΠΎΠ² ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΠΎΠ²Π°Π½Ρ‹Β ΠΊΠΎΠΌΠΌΠ΅Ρ€Ρ‡Π΅ΡΠΊΠΈ доступныС Π½Π°Π±ΠΎΡ€Ρ‹ для ΠΈΠΌΠΌΡƒΠ½ΠΎΡ„Π΅Ρ€ΠΌΠ΅Π½Ρ‚Π½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π°. Π£ всСх Π²ΠΊΠ»ΡŽΡ‡Π΅Π½Π½Ρ‹Ρ… Π»ΠΈΡ† сила сТатия кисти ΠΈΠ·ΠΌΠ΅Ρ€ΡΠ»Π°ΡΡŒ Ρ€ΡƒΡ‡Π½Ρ‹ΠΌ Π΄ΠΈΠ½Π°ΠΌΠΎΠΌΠ΅Ρ‚Ρ€ΠΎΠΌ. Π˜Π½ΡΡƒΠ»ΠΈΠ½ΠΎΠΏΠΎΠ΄ΠΎΠ±Π½Ρ‹ΠΉ Ρ„Π°ΠΊΡ‚ΠΎΡ€ роста 1 (ИЀР-1) ΠΈ свободный ΠΊΠΎΡ€Ρ‚ΠΈΠ·ΠΎΠ» Π² суточной ΠΌΠΎΡ‡Π΅Β ΠΎΠΏΡ€Π΅Π΄Π΅Π»ΡΠ»ΠΈΡΡŒ ΠΈΠΌΠΌΡƒΠ½ΠΎΡ…Π΅ΠΌΠΈΠ»ΡŽΠΌΠΈΠ½Π΅ΡΡ†Π΅Π½Ρ‚Π½Ρ‹ΠΌ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠΌ, свободный ΠΊΠΎΡ€Ρ‚ΠΈΠ·ΠΎΠ» Π² слюнС - ΡΠ»Π΅ΠΊΡ‚Ρ€ΠΎΡ…Π΅ΠΌΠΈΠ»ΡŽΠΌΠΈΠ½Π΅ΡΡ†Π΅Π½Ρ‚Π½Ρ‹ΠΌ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠΌ. Для ΠΎΡ†Π΅Π½ΠΊΠΈ Ρ€Π°Π·Π»ΠΈΡ‡ΠΈΠΉ ΠΌΠ΅ΠΆΠ΄Ρƒ Π³Ρ€ΡƒΠΏΠΏΠ°ΠΌΠΈ использован ΠΎΠ΄Π½ΠΎΡ„Π°ΠΊΡ‚ΠΎΡ€Π½Ρ‹ΠΉ диспСрсионный Π°Π½Π°Π»ΠΈΠ· ANOVA.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹: Π’ исслСдованиС Π²ΠΊΠ»ΡŽΡ‡Π΅Π½Ρ‹ 88 Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊ [30 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с болСзнью Π˜Ρ†Π΅Π½ΠΊΠΎ-ΠšΡƒΡˆΠΈΠ½Π³Π° (Π³Ρ€ΡƒΠΏΠΏΠ° 1), 28 с Π°ΠΊΡ€ΠΎΠΌΠ΅Π³Π°Π»ΠΈΠ΅ΠΉ (Π³Ρ€ΡƒΠΏΠΏΠ° 2) ΠΈ 30 условно Π·Π΄ΠΎΡ€ΠΎΠ²Ρ‹Ρ… Π»ΠΈΡ† (Π³Ρ€ΡƒΠΏΠΏΠ° 3)], Π±Π΅Π· Ρ€Π°Π·Π»ΠΈΡ‡ΠΈΠΉ ΠΏΠΎ ΠΏΠΎΠ»Ρƒ, возрасту ΠΈ ИМВ ΠΌΠ΅ΠΆΠ΄Ρƒ Π³Ρ€ΡƒΠΏΠΏΠ°ΠΌΠΈ (p=0,492, 0,062 ΠΈΒ 0,174 соотвСтствСнно). Π‘Ρ€Π΅Π΄Π½Π΅Π΅ Π·Π½Π°Ρ‡Π΅Π½ΠΈΠ΅ свободного ΠΊΠΎΡ€Ρ‚ΠΈΠ·ΠΎΠ»Π° Π² суточной ΠΌΠΎΡ‡Π΅ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Π‘Π˜Πš ΠΈ срСдний ΡƒΡ€ΠΎΠ²Π΅Π½ΡŒ ИРЀ-1 Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Π°ΠΊΡ€ΠΎΠΌΠ΅Π³Π°Π»ΠΈΠ΅ΠΉ Π±Ρ‹Π»ΠΈ Π·Π½Π°Ρ‡ΠΈΠΌΠΎ Π²Ρ‹ΡˆΠ΅, Π½Π΅ΠΆΠ΅Π»ΠΈ Π² Π΄Ρ€ΡƒΠ³ΠΈΡ… Π³Ρ€ΡƒΠΏΠΏΠ°Ρ… (p0,001). Π‘ΠΈΠ»Π° сТатия ΠΏΡ€Π°Π²ΠΎΠΉ кисти Π±Ρ‹Π»Π° Π½ΠΈΠΆΠ΅ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Π‘Π˜Πš ΠΏΠΎ ΡΡ€Π°Π²Π½Π΅Π½ΠΈΡŽ с ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Π°ΠΌΠΈ, ΡΡ‚Ρ€Π°Π΄Π°ΡŽΡ‰ΠΈΠΌΠΈ Π°ΠΊΡ€ΠΎΠΌΠ΅Π³Π°Π»ΠΈΠ΅ΠΉ ΠΈ со Π·Π΄ΠΎΡ€ΠΎΠ²Ρ‹ΠΌΠΈ Π»ΠΈΡ†Π°ΠΌΠΈ (p=0,04). Однако Π½Π΅ Π±Ρ‹Π»ΠΎ Π½Π°ΠΉΠ΄Π΅Π½ΠΎ статистичСски Π·Π½Π°Ρ‡ΠΈΠΌΡ‹Ρ… Ρ€Π°Π·Π»ΠΈΡ‡ΠΈΠΉ Π² ΠΈΠ·ΠΌΠ΅Ρ€Π΅Π½Π½Ρ‹Ρ… уровнях ΠΌΠΈΠΎΠΊΠΈΠ½ΠΎΠ²: ΠΈΡ€ΠΈΠ·ΠΈΠ½ - p=0,15; Π˜Π›-6 - p=0,34; миостатин - p=0,50. Π’ ΠΊΠ°ΠΆΠ΄ΠΎΠΉ ΠΏΠΎΠ΄Π³Ρ€ΡƒΠΏΠΏΠ΅ ΠΈ Π² Ρ†Π΅Π»ΠΎΠΌ срСди ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² имСлась коррСляционная связь ΠΌΠ΅ΠΆΠ΄Ρƒ ΡƒΡ€ΠΎΠ²Π½Π΅ΠΌ миостатина ΠΈ ΠΈΡ€ΠΈΠ·ΠΈΠ½Π° (p0,001), Π½ΠΎ Π½Π΅ Π˜Π›-6. НС выявлСно зависимости ΠΌΠ΅ΠΆΠ΄Ρƒ ΡƒΡ€ΠΎΠ²Π½Π΅ΠΌ ΠΌΠΈΠΎΠΊΠΈΠ½ΠΎΠ² ΠΈ ΠΊΠΎΡ€Ρ‚ΠΈΠ·ΠΎΠ»ΠΎΠΌ Π² суточной ΠΌΠΎΡ‡Π΅ ΠΈΠ»ΠΈ ИРЀ1 ΠΊΠ°ΠΊ Π² Ρ†Π΅Π»ΠΎΠΌ, Ρ‚Π°ΠΊ ΠΈ Π² ΠΎΡ‚Π΄Π΅Π»ΡŒΠ½Ρ‹Ρ… Π³Ρ€ΡƒΠΏΠΏΠ°Ρ….Π’Ρ‹Π²ΠΎΠ΄: эндогСнный Π³ΠΈΠΏΠ΅Ρ€ΠΊΠΎΡ€Ρ‚ΠΈΡ†ΠΈΠ·ΠΌ (болСзнь Π˜Ρ†Π΅Π½ΠΊΠΎ-ΠšΡƒΡˆΠΈΠ½Π³Π°) ΠΈ супрафизиологичСский ΡƒΡ€ΠΎΠ²Π΅Π½ΡŒ ИРЀ-1 Π·Π½Π°Ρ‡ΠΈΠΌΠΎ Π½Π΅ Π²Π»ΠΈΡΡŽΡ‚ Π½Π° сывороточныС ΡƒΡ€ΠΎΠ²Π½ΠΈ миостатина, Π˜Π›-6 ΠΈ ΠΈΡ€ΠΈΠ·ΠΈΠ½Π° Ρƒ ΠΌΠΎΠ»ΠΎΠ΄Ρ‹Ρ… ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ²

    CMS physics technical design report : Addendum on high density QCD with heavy ions

    Get PDF
    Peer reviewe

    Observation of a new boson at a mass of 125 GeV with the CMS experiment at the LHC

    Get PDF

    Hyperprolactinemic hypogonadism (classification, clinical picture and treatment)

    No full text
    Available from VNTIC / VNTIC - Scientific & Technical Information Centre of RussiaSIGLERURussian Federatio

    PROSTHODONTICS IS IN YOUR FUTURE

    No full text

    Cristobalite-related phases in the KAlO2-KAlSiO4 system

    No full text
    A study of the K-rich end of the potassium aluminate-silica system (K1-xAl1-xSixO2; 0≀x≀0.25) at temperatures up to 1500Β°C has confirmed the existence of a cubic cristobalite-type solid solution extending to xβ‰ˆ0.235 at 1500Β°C. The end member, KAl

    Selective gas adsorption by amorphous clay mineral derivatives

    No full text
    Amorphous derivates prepared by aqueous reaction of various aluminosilicate clay minerals with concentrated KF solution at 80-110Β°C were studied for their gas adsorption properties. The four clay minerals studied are halloysite, a well-crystallized kaol
    corecore